Michael Rehdelfs

Michael Rehdelfs is an experienced professional in the pharmaceutical and biotech industries, currently serving as Associate Director Clinical Portfolio at BioNTech SE since September 2022. Prior roles include Head of Quality Assurance and Deputy Head of Quality Assurance at Vibalogics, along with leadership positions in quality control and production at Bodechemie and Novartis Deutschland. Michael has also contributed to quality assurance at Aspen Pharma Group and completed traineeships in regulatory affairs and quality assurance at HELM AG. Michael holds a degree from The Philipp University of Marburg.